U.S. Software Stock News

If you are wondering whether Marriott International's current share price still offers value after a strong run in recent years, you are not alone. The stock recently closed at US$313.81, with a 7 day return of 3.1% decline, a 30 day return of 11.3% decline, a 1 year return of 30.3% and a 3 year return of 103.6% that puts longer term performance in focus. Recent news flow around large hotel groups has focused on travel demand trends and how global operators are positioning their brands and...

Bausch + Lomb recently faced a Portnoy Law Firm investigation into possible securities fraud after disclosing a voluntary recall of its enVista intraocular lenses linked to increased reports of toxic anterior segment syndrome, which the company said would create headwinds for revenue and adjusted EBITDA. At the same time, CEO and Chairman Brenton L. Saunders’ presentation at the Longwood Healthcare Leaders Miami conference offered investors a forum to gauge how management addresses the...

If you are wondering whether S&T Bancorp at around US$40.20 is offering fair value or a possible bargain, you are not alone, and this article is designed to help you frame that question clearly. The stock has seen mixed recent returns, with a 1.3% decline over the last week and an 8.0% decline over the last 30 days, set against gains of 2.4% year to date, 8.5% over 1 year, 38.6% over 3 years and 42.6% over 5 years. Recent attention on regional banks, along with continuing investor focus on...

Several Diamondback Energy (NasdaqGS:FANG) executives, including the CEO, recently recorded sizeable insider stock sales. The transactions occurred shortly before the company’s shares reached a 52 week high. The sales followed a large secondary offering by a major shareholder, adding to the volume of FANG stock changing hands. Diamondback Energy focuses on oil and gas exploration and production in the Permian Basin, a key region for US shale output. The sector continues to be influenced by...

Arthur J. Gallagher (AJG) is back in the spotlight after upgrades from Barclays and Mizuho, with both banks pointing to resilient brokerage fundamentals and durable sector tailwinds, despite recent earnings-related volatility and AI concerns. See our latest analysis for Arthur J. Gallagher. At a latest share price of US$207.93, Arthur J. Gallagher’s 1-day share price return of 1.82% comes after a sharp 7-day share price decline of 8.85%. Earnings-related volatility, acquisitions and board...

If you are wondering whether Sirius XM Holdings is still worth a place in your portfolio at today’s price, this article walks through what the current market valuation might be implying. The stock recently closed at US$21.99, with returns of 3.3% over the past 30 days, 7.2% year to date, 2.0% over the last year, and longer term 3 year and 5 year returns of 32.5% and 56.9% declines respectively. This tells a very different story depending on your time frame. Recent coverage has focused on...

Pfizer has started new clinical studies tied to its tafamidis and etrasimod franchises, including a Phase 1 tafamidis bioequivalence trial. The company is advancing a next generation pneumococcal conjugate vaccine program to the next stage of clinical development. Pfizer has also initiated an early stage oncology trial as part of a broader pipeline refresh beyond its existing franchises. Pfizer, listed as NYSE:PFE, is updating its clinical pipeline at a time when its share price sits at...

If you are wondering whether Corebridge Financial's current share price really reflects what the business is worth, this article will walk through the key numbers that matter for valuation. The stock closed at US$23.49, with returns of a 7.3% decline over the past week, a 24.4% decline over the past month, and a 22.7% decline year to date. The 3 year return sits at 83.1% and the 1 year return at a 23.9% decline. Recent coverage around Corebridge Financial has focused on its position within...

Earlier this week, Oracle reported an exceptionally strong fiscal Q3 2026, with cloud and AI infrastructure demand driving revenue and earnings above expectations and prompting higher guidance for fiscal 2027 revenues of US$90.00 billion. The quarter also revealed a very large US$553.00 billion remaining performance obligation tied to long-term AI infrastructure contracts, underscoring how deeply Oracle is embedding itself in customers’ mission-critical workloads. We’ll now look at how this...

TransUnion cut pricing on its VantageScore 4.0 mortgage origination score, aiming to lower credit scoring costs for lenders and homebuyers. The company is offering the score at a major discount and bundling free access alongside FICO scores. This move positions TransUnion as the first major credit bureau to make a large cut tied directly to mortgage affordability and competition. TransUnion (NYSE:TRU), recently trading at $69.95, is making this change at a time when its share price is down...

Arlo Technologies (ARLO) is back in focus after reporting quarterly results that topped analyst expectations and unveiling a US$50 million share repurchase program running through 2027, which signals management’s confidence in its services led model. See our latest analysis for Arlo Technologies. The latest results and buyback news come after a period where momentum has been building, with a 19.09% 1 month share price return and a 27.94% 1 year total shareholder return, alongside a 135.70%...

On March 11, 2026, ZTO Express cancelled 7.37 million repurchased Class A shares, trimming its total Class A share count by about 0.93%. This relatively small cancellation slightly increases each remaining shareholder’s ownership stake and underlines management’s focus on active capital management and regulatory transparency. Next, we’ll explore how this recent share cancellation, which incrementally lifts per-share ownership, may influence ZTO Express’s broader investment...

Assurant (AIZ) has drawn investor attention after reporting fourth quarter and full year 2025 results that included 17% growth in net operating income per share and 7.5% revenue growth, along with positive 2026 adjusted EBITDA guidance. See our latest analysis for Assurant. At a share price of $218.53, Assurant’s recent 1 day share price return of 1.50% comes after a softer period, with a 90 day share price return decline of 6.31%. Its 3 year total shareholder return of about 2x suggests...

Terns Pharmaceuticals recently attracted renewed attention after updating its corporate presentation with refreshed pipeline timelines and milestones, while also being selected for inclusion in a STOXX benchmark index effective March 23, 2026. This combination of clearer development visibility, impending index inclusion, and investor focus on the upcoming earnings update has sharpened debate around the company’s long-term prospects and current financial pressures. With investors now closely...

Why United Community Banks Stock Is On Watch United Community Banks (UCB) has seen its share price under pressure recently, with a roughly 13% decline over the past month and about a 7% decline in the past 3 months, prompting closer investor attention. See our latest analysis for United Community Banks. That recent 13% 30 day share price pullback comes after a softer 90 day share price return of about 7% and contrasts with a 1 year total shareholder return of 8.6%. This hints that near term...

Lowe's Companies (LOW) moved into focus after strong Q4 2025 results were followed by cautious 2026 guidance, a new Neutral rating from KGI Securities, and fresh selling pressure from institutional investors. See our latest analysis for Lowe's Companies. The mixed reaction to Lowe's fourth quarter and FY 2026 outlook has coincided with a 17.33% 1 month share price decline and weaker near term momentum, even as the 1 year total shareholder return of 7.99% and 3 year total shareholder return of...

Baidu (BIDU) has drawn fresh attention after Baidu AI Cloud launched DuClaw, a zero deployment service that gives instant access to the OpenClaw agent platform and Baidu’s core information tools through a fully managed web interface. See our latest analysis for Baidu. Baidu’s DuClaw launch lands at a time when the company’s 7 day share price return of 4.22% contrasts with a 30 day share price decline of 9.44%. Over a 1 year period, the total shareholder return of 32.24% sits against a weaker...

Context for Forestar Group after recent trading moves Forestar Group (FOR) has seen mixed share performance recently, with a 1 day gain of 1.6% contrasting with declines over the past week, month, and past 3 months, which may prompt investors to reassess the stock. See our latest analysis for Forestar Group. Zooming out, Forestar Group’s recent 1 day share price gain sits against a weaker patch, with a 30 day share price return of a 16.4% decline but a 3 year total shareholder return of...

Restaurant Brands International (QSR) is back in focus after reporting earnings that exceeded analyst expectations, supported by sales growth at Tim Hortons, Burger King, and Popeyes, along with an increased dividend and active brand investment. See our latest analysis for Restaurant Brands International. The latest results and dividend increase come after a mixed few months for investors, with a 9.84% 1 month share price return helping offset earlier weakness and contributing to a 14.13% 1...

Home Bancshares stock performance snapshot Home Bancshares (HOMB) has been trading under pressure recently, with the share price around $26.31 and negative returns over the past week, month, past 3 months, year to date, and past year. At the same time, the bank reports annual revenue of about $1.07b and net income of roughly $475.44m, alongside positive multi year total returns. This presents investors with a mixed set of signals to weigh. See our latest analysis for Home Bancshares (Conway...

In early March 2026, Match Group, Inc. announced that the Chief Operating Officer role will be eliminated on June 2, 2026, leading long-time executive Hesam Hosseini to depart after more than 15 years with the company. This leadership change comes as analysts highlight faster product experimentation and early engagement improvements at Tinder, raising questions about how Match Group’s operating structure will support its product-led refresh. We’ll now examine how Tinder’s faster product...

MicroVision’s latest earnings draw investor focus MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million. See our latest analysis for MicroVision. Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as...

In recent months, Haemonetics has reported a recovery in its Hospital division, underpinned by growing adoption of its FDA-approved NexSys PCS system with Persona Technology and supported by acquisitions broadening its presence in esophageal protection and interventional cardiology. An interesting angle is how this combination of higher-margin NexSys PCS usage and newly acquired hospital technologies is helping Haemonetics improve operational efficiency while deepening its role inside...

Why ServiceTitan stock is back in focus ServiceTitan (TTAN) is drawing fresh attention after a busy set of March updates, including fourth quarter and full year results, new revenue guidance, and a leadership hire focused squarely on AI. See our latest analysis for ServiceTitan. ServiceTitan shares have been volatile around the recent earnings release and AI focused leadership appointment, with a 1 day share price return of 6.41% decline and a 7 day share price return of 14.65% decline. The...